Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-05
1999-11-23
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514361, 514639, 514646, 514647, A61K 3144, A61K 3141, A61K 3115, A61K 31135
Patent
active
059901373
ABSTRACT:
The instant methods employs pharmaceutical compositions comprising aromatic azines; and imines, of the Formula 1 to selectively inhibit inflammation by preventing the oxidating burst from phagocytic leukocytes caused by NADPH Oxidase.
REFERENCES:
patent: 4015014 (1977-03-01), Vatne et al.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4564636 (1986-01-01), Kaplan
Dewhirst, "Structure-Activity Relationships for Inhibition of Prostaglandin Cyclooxygenase by Phenolic Compounds," Prostaglandins 20(2): 209-222, 1980.
Gaur et al., Chemical Abstract 116: Abstract No. 151378u, 1992.
Hansen et al., "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill," Journal of Immunological Methods 119: 203-210, 1989.
Hogquist et al., "Release of IL-1 From Mononuclear Phagocytes," J. Immunology 147: 2181-2186, 1991.
Machon and Ryng, "Synthesis and Biological Properties of 5-Benzoylamino-3-Methyl-4-Isoxazolocarboxylic Acid Derivatives," Arch. Immunol. Ther. Exp. 29(6): 813-821, 1981.
Mosmann, "Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays," Journal of Immunological Methods 65: 55-63, 1983.
Mrowietz et al., "Inhibition of Human Monocyte Functions by Anthralin," British Journal of Dermatology 127: 382-386, 1992.
Ramanathan et al., "Biological Activity of Some 2-Amino 4,5,6,7-Tetrahydro Benzo (b)-Thiophenes and Their Derivatives," J. Indian Chem. Soc. LV: 822-825, 1978.
Slater et al., "Studies on Succinate-Tetrazolium Reductase Systems, III. Points of Coupling of Four Different Tetrazolium Salts," Biochim. Biophys. Acta. 77: 383-393, 1963.
Sozzani et al., "The Signal Transduction Pathway Involved in the Migration Induced by a Monocyte Chemotactic Cytokine," The Journal of Immunology 147: 2215-2221, 1991.
Stolk et al., "Characteristics of the Inhibition of NADPH Oxidase Activation in Neutrophilis by Apocynin, a Methoxy-substituted Catechol," Am. J. Respir. Cell Mol. Biol. 11: 95-102, 1994.
Synderman, "Methods for Studying Mononuclear Phagocytes," Adams et al. (eds.), Academic Press, New York, 1981, pp. 535-547.
Wahl et al., "Current Protocols in Immunology," Coligan et al. (eds.), 1991, p. 7.6.1.
Wahl et al., "Isolation of Human Mononuclear Cell Subsets by Counterflow Centrifugal Elutriation (CCE)," Cellular Immunology 85: 373-383, 1984.
Zigmond et la., "Leukocyte Locomotion and Chemotaxis," The Journal of Experimental Medicine 137: 387-410, 1973.
Karanewsky Donald S.
Ternansky Robert J.
Valentino Karen L.
Criares Theodore J.
Idun Pharmaceuticals, Inc.
LandOfFree
Method of inhibiting NADPH oxidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting NADPH oxidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting NADPH oxidase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222342